Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 16651-16700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06661967
Topical Oral Anesthesia Adjuncts in Conventional Intubation on First-Pass Success Rate
NARecruiting
110 participants
Started: Oct 25, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06078007
Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)
NARecruiting
600 participants
Started: Oct 25, 2024 · Completed: Nov 30, 2025
2 conditions8 sponsors1 location
NCT06365216
ALS Phase II Study of NX210c
PHASE2Recruiting
80 participants
Started: Oct 25, 2024 · Completed: Feb 1, 2026
1 condition2 sponsors12 locations
NCT06557343
Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy
N/ARecruiting
5 participants
Started: Oct 25, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05927519
Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
NARecruiting
80 participants
Started: Oct 25, 2024 · Completed: Oct 5, 2027
4 conditions1 sponsor2 locations
NCT06769282
Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
NARecruiting
88 participants
Started: Oct 25, 2024 · Completed: Mar 30, 2027
2 conditions2 sponsors1 location
NCT06490250
Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients
NARecruiting
51 participants
Started: Oct 25, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06572423
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
NARecruiting
43 participants
Started: Oct 25, 2024 · Completed: Dec 16, 2029
4 conditions2 sponsors1 location
NCT06598670
Transcranial Direct Current Stimulation on Post Stroke Depression
NARecruiting
56 participants
Started: Oct 25, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06739135
Driving with Neuropathy
NARecruiting
115 participants
Started: Oct 25, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06455475
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
NARecruiting
150 participants
Started: Oct 25, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor11 locations
NCT07167667
Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities
NARecruiting
60 participants
Started: Oct 25, 2024 · Completed: Oct 25, 2025
1 condition1 sponsor1 location
NCT06458504
Viral Infection of HSPC Impacts Hematopoiesis
N/ARecruiting
45 participants
Started: Oct 25, 2024 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT06572839
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
NARecruiting
150 participants
Started: Oct 25, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor12 locations
NCT06635213
Effectiveness of Desensitisation and Pain Neuroscience Education in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain
NARecruiting
40 participants
Started: Oct 25, 2024 · Completed: Jun 10, 2027
1 condition1 sponsor1 location
NCT06638307
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1Recruiting
240 participants
Started: Oct 25, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor38 locations
NCT06606171
Floor Sitting Study
NARecruiting
40 participants
Started: Oct 25, 2024 · Completed: Mar 30, 2025
3 conditions1 sponsor1 location
NCT05379712
Nutritional Supplementation in Head and Neck Cancers
PHASE2Recruiting
81 participants
Started: Oct 25, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT06450873
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
PHASE2Recruiting
100 participants
Started: Oct 25, 2024 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT06607588
Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
N/ARecruiting
200 participants
Started: Oct 25, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06371833
PRIMA EU Retrospective & Prospective
N/ARecruiting
60 participants
Started: Oct 25, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06117306
MDMA-assisted Massed Prolonged Exposure for PTSD
PHASE3Recruiting
20 participants
Started: Oct 25, 2024 · Completed: Jan 1, 2026
1 condition5 sponsors1 location
NCT04860570
Are Double-ring Wound-edge Protectors Effective for Preventing Superficial Surgical Site Infection After Open Appendectomy?
N/ARecruiting
671 participants
Started: Oct 25, 2024 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06545968
A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda
NARecruiting
105 participants
Started: Oct 25, 2024 · Completed: Jan 30, 2028
1 condition2 sponsors1 location
NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
PHASE1/PHASE2Recruiting
232 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06687746
Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns
N/ARecruiting
5,400 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2025
5 conditions10 sponsors6 locations
NCT06487286
Levels of Visfatin/NAMPT in Human Milk
N/ARecruiting
30 participants
Started: Oct 24, 2024 · Completed: Apr 23, 2025
2 conditions2 sponsors1 location
NCT06593106
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
NARecruiting
30 participants
Started: Oct 24, 2024 · Completed: Aug 31, 2026
2 conditions3 sponsors1 location
NCT06182293
Periodontal Microbiota in Systemic Sclerosis
NARecruiting
30 participants
Started: Oct 24, 2024 · Completed: Oct 24, 2025
1 condition1 sponsor1 location
NCT06475937
A Study of DM001 in Patients With Advanced Solid Tumors
PHASE1Recruiting
128 participants
Started: Oct 24, 2024 · Completed: Feb 13, 2027
3 conditions1 sponsor5 locations
NCT06637163
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
PHASE2Recruiting
100 participants
Started: Oct 24, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor5 locations
NCT06522152
Evaluation of Clinical-functional and Radiographic Outcomes in Patients Who Underwent Meniscal Allograft Transplantation (MAT) at 10 Years.
N/ARecruiting
397 participants
Started: Oct 24, 2024 · Completed: Jul 31, 2030
2 conditions1 sponsor1 location
NCT06681610
Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study
NARecruiting
50 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06662227
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
EARLY_PHASE1Recruiting
30 participants
Started: Oct 24, 2024 · Completed: Dec 30, 2029
3 conditions2 sponsors1 location
NCT06639256
Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
258 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT06613880
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
PHASE2Recruiting
48 participants
Started: Oct 24, 2024 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT06646172
Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy
NARecruiting
38 participants
Started: Oct 24, 2024 · Completed: Oct 12, 2026
1 condition1 sponsor1 location
NCT06532500
I-CARE: A Pilot Study of Cognitive Behavioural Therapy(CBT) for Mood and Anxiety Disorders
NARecruiting
50 participants
Started: Oct 24, 2024 · Completed: Sep 1, 2027
2 conditions1 sponsor1 location
NCT06358573
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
PHASE2Recruiting
54 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2029
2 conditions1 sponsor9 locations
NCT06546956
Integrative Breathwork Intervention for Chronic Pain
PHASE1/PHASE2Recruiting
30 participants
Started: Oct 24, 2024 · Completed: May 22, 2027
1 condition2 sponsors1 location
NCT06665412
Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML
N/ARecruiting
168 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT06664047
Over-the-Top vs. Anteromedial ACLR With Lateral Extraarticular Tenodesis
NARecruiting
150 participants
Started: Oct 24, 2024 · Completed: Nov 1, 2028
3 conditions1 sponsor1 location
NCT06558227
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
PHASE2Recruiting
90 participants
Started: Oct 24, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06291350
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
N/ARecruiting
45 participants
Started: Oct 24, 2024 · Completed: Nov 15, 2026
2 conditions1 sponsor3 locations
NCT05810571
Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study
NARecruiting
60 participants
Started: Oct 24, 2024 · Completed: Jan 3, 2027
1 condition1 sponsor2 locations
NCT06624436
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
PHASE4Recruiting
52 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT06910878
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
N/ARecruiting
100 participants
Started: Oct 24, 2024 · Completed: Dec 24, 2025
1 condition1 sponsor1 location
NCT07101601
Study of DM5167 in Patients With Advanced Solid Tumors
PHASE1Recruiting
58 participants
Started: Oct 24, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor4 locations
NCT06653634
Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
PHASE4Recruiting
150 participants
Started: Oct 24, 2024 · Completed: Dec 31, 2029
1 condition4 sponsors7 locations
NCT06671938
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
PHASE2Recruiting
36 participants
Started: Oct 24, 2024 · Completed: Mar 16, 2026
2 conditions2 sponsors8 locations